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Editorial 
Dysarthria can have profound effects on children’s quality of life and social 
participation (1, 2). Despite such impacts, there has been a critical lack of research 
investigating the causes, treatment and outcomes of childhood dysarthria compared to 
other paediatric speech-language disorders. For example, a simple search in Pubmed 
reveals a literature ratio of around 1:3.5 for dysarthria treatment compared to speech 
sound disorder treatments (child* dysarthria treatment, 398 results vs. child* 
articulation treatment and/or phonological treatment, 1441 results), and an even 
greater ratio (1:41) for dysarthria versus child language treatment literature (child* 
language treatment, 16267 results). More importantly, the level of evidence for 
treating childhood dysarthria is low. No studies were identified that met inclusion 
criteria for meta-analyses examining treatment efficacy in the Cochrane Database of 
Systematic Reviews (see Pennington et al., 2009 for dysarthria acquired under 3 
years; Morgan et al., 2008 for dysarthria acquired from 3 years and upwards). By 
contrast, a number of papers met inclusion criteria for a Cochrane review on efficacy 
of treatment for developmental speech and language disorders (Law et al., 2003; 
updated 2010). There is a clear need to generate robust evidence to support 
interventions for children with dysarthria, and integrated measures to evaluate their 
outcomes. 
 With this need in mind, we gathered a group of international scholars who 
share the goal of improving the clinical management of these children to contribute 
original research studies to this Special Issue, “Translating Knowledge into Practice in 
Childhood Dysarthria”. It is an exciting time to focus on this population of children 
because the World Health Organization’s International Classification of Functioning, 
Disability and Health (ICF) has given researchers and clinician’s a newfound 
recognition of the need to consider, and where possible, modify how dysarthria 
impacts an individual’s activity and participation in daily life. This issue is organised 
so that aspects of impairment, activity and participation are covered by the invited 
authors. 
 A relative strength of the extant literature is the characterisation of speech 
deficits or speech impairment in children with dysarthria. Our Special Edition builds 
on this strength. Ann Nordberg and colleagues examined speech impairment, 
cognitive level and gross motor function in children with CP and report that level of 
nonverbal cognitive impairment, rather than level of gross motor impairment, may be 
of greatest relevance when considering management of speech treatment in this 
population. At the level of communication activity, Kristen Allison and Katie Hustad 
investigated the effects of two important linguistic variables - sentence length and 
phonetic complexity - on the intelligibility of children with CP. They highlight the 
need for information from measures at levels of both body function and activity to 
plan treatment for an individual child. Further insights into the complex issue of 
intelligibility for children with dysarthria are provided by Sophie Landa and 
colleagues who examine the association between listeners’ perceptions of the ease of 
understanding dysarthric speech and the amount of speech they actually understand. 
This work provides an important conceptual leap in the field, providing measures of 
the impact of listener, as well as speaker, factors on intelligibility. 
 
 A critical issue limiting our ability to measure intelligibility and associated 
measures of speaking rate in children with dysarthria has been a lack of standard tools 
for eliciting connected speech. Megan Hodge is a pioneer in this regard and here 
reports criterion reliability data for the Test of Children’s Speech Plus, compared to 
children’s conversational speech samples. Rupal Patel’s contribution also augments 
our ability to assess dysarthric speech by providing the first picture description task; 
‘Play Park,’ which is designed specifically for eliciting connected speech in children 
with motor speech disorders. 
The work of Cristina Mei and colleagues extends the scope of the 
contributions focused at the impairment and activity levels by describing the impact 
of motor speech impairment on activity and participation in the home, school and 
community in a cohort study of children with CP. As anticipated, limitations in 
activity and participation were found to increase as motor speech ability and speech 
intelligibility decreased. 
We’re delighted that three manuscripts are dedicated to treatment of children 
with dysarthria. For the past two decades, the Lee Silverman Voice Treatment 
(LSVT) program has been at the forefront of rigorous dysarthria treatments in adults 
and is increasingly applied to children. In this Special Issue, Carol Boliek and Cynthia 
Fox discuss two case studies, described as one weak and one strong responder to 
LSVT LOUD. In particular, they demonstrate how individual and environmental 
features may affect immediate and lasting responses to treatment. Erika Levy also 
presents findings from implementing LSVT LOUD and Pennington and colleagues’ 
Speech Systems Intelligibility Treatment in children with CP. She discusses specific 
strategies for outcome measurement including acoustic analysis of dysarthric speech. 
Roslyn Ward and colleagues also discuss a well known speech treatment approach, 
the Prompts for Restructuring Oral Motor Targets (PROMPT) program and 
demonstrate promise for its utility in children with dysarthria. 
 We are proud that this special issue also considers outcomes in paediatric 
dysarthria at a more global level. Pamela Enderby challenges us to account for our 
practice and improve our clinical outcome measurement. She encourages us to think 
at a broader level of health care service provision, to strive to bench mark our practice 
within and across services, at and beyond an individual patient level. Her paper 
describes an important extension of TOMS that reflects the impact of the range of 
treatments for childhood dysarthria, with practical real world examples to facilitate 
our learning. 
 We thank the authors for their valuable contributions.  We trust that these 
papers will increase readers’ awareness and understanding of the multifaceted and 
complex issues in childhood dysarthria and inspire some to continue to build a much-
needed research base on this topic, cast within the ICF-CY framework. 
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